Addex Therapeutics (ADXN) Assets (2022 - 2025)
Historic Assets for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $9.2 million.
- Addex Therapeutics' Assets fell 3475.08% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year decrease of 3475.08%. This contributed to the annual value of $12.1 million for FY2024, which is 13484.77% up from last year.
- Per Addex Therapeutics' latest filing, its Assets stood at $9.2 million for Q3 2025, which was down 3475.08% from $10.3 million recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Assets ranged from a high of $19.1 million in Q1 2022 and a low of $3.8 million during Q1 2024
- In the last 4 years, Addex Therapeutics' Assets had a median value of $10.3 million in 2025 and averaged $10.5 million.
- Its Assets has fluctuated over the past 5 years, first plummeted by 5880.71% in 2023, then surged by 17600.8% in 2025.
- Quarter analysis of 4 years shows Addex Therapeutics' Assets stood at $8.6 million in 2022, then tumbled by 39.13% to $5.2 million in 2023, then soared by 132.93% to $12.2 million in 2024, then decreased by 24.82% to $9.2 million in 2025.
- Its Assets stands at $9.2 million for Q3 2025, versus $10.3 million for Q2 2025 and $10.5 million for Q1 2025.